Many drugs are known to cause lengthening of the QT interval. Ibandronic acid is a frequently used agent in the treatment of osteoporosis and is known to cause prolongation of the QT interval due to hypocalcaemia. However, no cases of long QT syndrome associated with ventricular tachycardia (VT) with a serum calcium level within the normal limits have been reported in the literature. We report on a case of a VT-based long QT syndrome associated with the use of ibandronic acid.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5830/CVJA-2013-037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bone-Marrow-Targeted Nanocomposite Abrogates C-Myb-Survivin Cross Talk in MLL-AF9-Rearranged Acute Myeloid Leukemia in and Patient-Derived Xenograft Models.
ACS Appl Mater Interfaces
December 2024
Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.
The heterogeneous form of malignancy in the myeloid lineage of normal hematopoietic stem cells (HSCs) is characterized as acute myeloid leukemia (AML). The t(9;11) reciprocal translocation (p22;q23) generates MLL-AF9 oncogene, which results in myeloid-based monoblastic AML with frequent relapse and poor survival. MLL-AF9 binds with the C-Myb promoter and regulates AML onset, maintenance, and survival.
View Article and Find Full Text PDFIn Vitro Effects of Some Chemotherapeutics on Human Erythrocyte Glucose-6-Phosphate Dehydrogenase Enzyme.
ACS Omega
December 2024
Faculty of Veterinary Science, Department of Biochemistry, Bingöl University, Bingöl 12000, Turkiye.
In this study; the in vitro effects of some drugs used in chemotherapy on the glucose-6-phosphate dehydrogenase enzyme (G6PD; E.C. 1.
View Article and Find Full Text PDFConcurrent Oral Squamous Cell Carcinoma and Bisphosphonate-Related Osteonecrosis of the Maxilla: A Case Report and Literature Review.
Head Neck
January 2025
Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Introduction: Bisphosphonates (BPs) are widely used for osteoporosis and cancer-induced bone diseases due to their antiresorptive properties, yet they pose risks such as medication-related osteonecrosis of the jaw (MRONJ).
Methods: We present a unique case of concurrent oral squamous cell carcinoma (SCC) and MRONJ in a 72-year-old female chronically treated with oral ibandronate for osteoporosis. Following a dental extraction, she developed a nonhealing wound in the maxilla.
Improved quality of life after Ibandronic acid infusion in patients suffering from diffuse sclerosing osteomyelitis of the jaw.
Med Oral Patol Oral Cir Bucal
November 2024
Department of Oral and Maxillofacial Surgery University of Munich, Lindwurmstr. 2a D-80337 Munich, Germany
Article Synopsis
- A cross-sectional study investigated the impact of Ibandronic acid on quality of life in patients with diffuse sclerosing osteomyelitis, focusing on 34 subjective health parameters.
- 15 patients completed standardized questionnaires before and two weeks after receiving 6mg of Ibandronic acid, reporting various improvements.
- All patients noted significant enhancements in quality of life, including better oral health, reduced pain, improved fatigue and emotional functioning, as well as fewer speech and swallowing issues.
Increased Uptake of 68 Ga-DOTA-IBA in Multiple Subcutaneous Metastases of Prostate Cancer.
Clin Nucl Med
November 2024
Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China.
Article Synopsis
- - A 66-year-old man with prostate cancer underwent a 68Ga-DOTA-ibandronic acid PET/CT scan to evaluate potential treatment with 177Lu-DOTA-IBA.
- - The scan revealed significant uptake in several osteoblastic bone metastases, indicating active cancer spread to the bones.
- - Unexpectedly, the scan also identified multiple subcutaneous metastases, which are rare in prostate cancer cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!